These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Ongoing||2004-002122-22||A prospective, multi-centre, double blind, randomized, placebo controlled trial to evaluate the safety and efficacy of ICXP007 in a phase III trial with four-layer therapeutic compression, for treatme...||not-yet-due|
|Ongoing||2006-000692-15||A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers||not-yet-due|
|Ongoing||2006-001415-29||A phase IIa uncontrolled study to evaluate hair growth in subjects with male-pattern baldness using a cell suspension of expanded autologous dermal papilla cells (ICX-TRC).||not-yet-due|
|Not reported||2006-003639-59||A phase IIa open-label dose-escalation study using ICX-RHY to enhance the aesthetic appearance of nasolabial folds||2008-05-08||due-trials|
|Ongoing||2006-006443-30||A phase IIa open-label study using ICX-RHY to enhance the aesthetic appearance of facial skin imperfections.||not-yet-due|
|Ongoing||2010-023121-38||A prospective placebo controlled phase II study to evaluate the use of allogeneic fibroblasts for the treatment of skin erosions in recessive dystrophic epidermolysis bulllosa.||not-yet-due|